Ameritas Investment Partners’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,728
| Closed | -$56K | – | 3066 |
|
|
2022
Q3 | $56K | Buy |
3,728
+622
| +20% | +$7.23K | ﹤0.01% | 1895 |
|
|
2022
Q2 | $23K | Hold |
3,106
| – | – | ﹤0.01% | 2500 |
|
|
2022
Q1 | $28K | Hold |
3,106
| – | – | ﹤0.01% | 2412 |
|
|
2021
Q4 | $22K | Hold |
3,106
| – | – | ﹤0.01% | 2613 |
|
|
2021
Q3 | $35K | Hold |
3,106
| – | – | ﹤0.01% | 2387 |
|
|
2021
Q2 | $50K | Hold |
3,106
| – | – | ﹤0.01% | 2193 |
|
|
2021
Q1 | $56K | Sell |
3,106
-500
| -14% | -$8.64K | ﹤0.01% | 2023 |
|
|
2020
Q4 | $49K | Hold |
3,606
| – | – | ﹤0.01% | 2008 |
|
|
2020
Q3 | $42K | Hold |
3,606
| – | – | ﹤0.01% | 1948 |
|
|
2020
Q2 | $53K | Hold |
3,606
| – | – | ﹤0.01% | 1793 |
|
|
2020
Q1 | $49K | Hold |
3,606
| – | – | ﹤0.01% | 1678 |
|
|
2019
Q4 | $87K | Hold |
3,606
| – | – | ﹤0.01% | 1600 |
|
|
2019
Q3 | $69K | Hold |
3,606
| – | – | ﹤0.01% | 1689 |
|
|
2019
Q2 | $107K | Buy |
3,606
+642
| +22% | +$24.7K | ﹤0.01% | 1464 |
|
|
2019
Q1 | $141K | Hold |
2,964
| – | – | 0.01% | 1251 |
|
|
2018
Q4 | $107K | Hold |
2,964
| – | – | 0.01% | 1328 |
|
|
2018
Q3 | $182K | Hold |
2,964
| – | – | 0.01% | 1147 |
|
|
2018
Q2 | $200K | Buy |
2,964
+159
| +6% | +$8.9K | 0.01% | 1068 |
|
|
2018
Q1 | $152K | Hold |
2,805
| – | – | 0.01% | 1233 |
|
|
2017
Q4 | $168K | Buy |
2,805
+140
| +5% | +$8.49K | 0.01% | 1182 |
|
|
2017
Q3 | $152K | Hold |
2,665
| – | – | 0.01% | 1215 |
|
|
2017
Q2 | $140K | Buy |
2,665
+275
| +12% | +$12.8K | 0.01% | 1256 |
|
|
2017
Q1 | $108K | Buy |
+2,390
| New | +$107K | 0.01% | 1385 |
|
Ameritas Investment Partners's AERI Position: Q4 2022 in Review
Ameritas Investment Partners sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 3,728 shares — an estimated $56K sold.
Ameritas Investment Partners first reported a position in AERI in Q1 2017 and held it in 23 quarters. The position peaked at $200K in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Ameritas Investment Partners reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Ameritas Investment Partners sold 3,728 Aerie Pharmaceuticals shares in Q4 2022, an estimated $56K.
- Ameritas Investment Partners first reported a position in Aerie Pharmaceuticals in Q1 2017 and held it in 23 quarters.
- Ameritas Investment Partners's Aerie Pharmaceuticals position peaked at $200K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Ameritas Investment Partners's 13F filing for Q4 2022, filed 13 Feb 2023.